For total CSF tau the sensitivity has been estimated to be 70–75 % and the specificity 74–90 % and for phospo-tau 79–88 % and 78–83 %, respectively, for separating AD from other dementias [9]. The gene discussed is MAPT; the disease is Alzheimer disease.